Skip to main content
SpringerLink
Log in

CD200 expression in T cell neoplasms

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Swerdlow SH, Campo E, Harris NL et al (2017) World Health Organization Classification of Tumors Haematopoietic and Lymphoid Tissues. IARC, Lyon, France

    Google Scholar 

  2. Moreaux J, Veyrune JL, Reme T, De Vos J, Klein B (2008) CD200: a putative therapeutic target in cancer. Biochem Biophys Res Commun 366(1). https://doi.org/10.1016/j.bbrc.2007.11.103

  3. Dorfman DM, Shahsafaei A (2011) CD200 (OX-2 membrane glycoprotein) is expressed by follicular T helper cells and in angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 35(1):76–83. https://doi.org/10.1097/PAS.0b013e31820065c9

    Article  PubMed  Google Scholar 

  4. Staub RB, Marcondes NA, Rotta LN (2021) CD200 expression in hematopoietic neoplasms: beyond a marker for diagnosis of B-cell neoplasms. Crit Rev Oncol Hematol:167. https://doi.org/10.1016/j.critrevonc.2021.103509

  5. Tonks A, Pearn L, Musson M et al (2007) Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukemia. Leukemia 21(12):2495–2505. https://doi.org/10.1038/sj.leu.2404961

    Article  CAS  PubMed  Google Scholar 

  6. Memarian A, Nourizadeh M, Masoumi F et al (2013) Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia. Tumor Biol 34(1):531–542. https://doi.org/10.1007/s13277-012-0578-x

    Article  CAS  Google Scholar 

  7. Tiribelli M, Raspadori D, Geromin A et al (2017) High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients. Leuk Res 58:31–38. https://doi.org/10.1016/j.leukres.2017.04.001

    Article  CAS  PubMed  Google Scholar 

  8. Gorczynski RM, Lee L, Boudakov I (2005) Augmented induction of CD4+CD25+ treg using monoclonal antibodies to CD200R. Transplantation 79(4):488–491. https://doi.org/10.1097/01.TP.0000152118.51622.F9

    Article  PubMed  Google Scholar 

  9. McWhirter JR, Kretz-Rommel A, Saven A et al (2006) Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation. Proc Natl Acad Sci USA 103(4):1041–1046. https://doi.org/10.1073/pnas.0510081103

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Health Sciences Graduate Program, Federal University of Health Sciences of Porto Alegre, 245, Sarmento Leite St, Porto Alegre, 90050-170, Brazil

    Renata Bartolomeu Staub & Liane Nanci Rotta

  2. Zanol Laboratory, Porto Alegre, Brazil

    Natália Aydos Marcondes, Bianca Michel Spindler, Flavo Beno Fernandes & Gustavo Adolpho Moreira Faulhaber

Authors
  1. Renata Bartolomeu Staub
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Natália Aydos Marcondes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bianca Michel Spindler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Flavo Beno Fernandes
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gustavo Adolpho Moreira Faulhaber
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Liane Nanci Rotta
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

RBS, NAM, and LNR made substantial contributions to conception and design, acquisition of data, analysis, and interpretation of data, as well as drafting the article or revising it critically for important intellectual content, final approval of the version to be published and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. BMS, FBF, and GAMF made substantial contributions to conception and design, acquisition of data, analysis, and interpretation of data.

Corresponding author

Correspondence to Renata Bartolomeu Staub.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Staub, R.B., Marcondes, N.A., Spindler, B.M. et al. CD200 expression in T cell neoplasms. Ann Hematol 102, 2285–2286 (2023). https://doi.org/10.1007/s00277-023-05264-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-023-05264-9

Search

Navigation